Cancer Talk

News

Roswell Park Comprehensive Cancer Center Tobacco Control Program Awarded $1M in Contracts

Roswell Park Comprehensive Cancer Center was awarded three contracts from the New York State Department of Health’s Bureau of Tobacco Control for regional tobacco control programs. Funding for the first year of the five-year contracts totals $1.05 million, supporting efforts to engage community stakeholders and area youth in changing policies and norms about tobacco and tobacco use throughout Western New York.
News

Roswell Park Now Offering Screening Mammograms for General Public

Roswell Park Cancer Institute (RPCI) announces the expansion of its breast imaging services to the general public, offering routine screening mammography to non-patients in an effort to improve breast cancer screening rates and increase detection of breast cancer at the earliest, most curable stages.
Dhyan Chandra, PhD
News

New Approach to Monitoring Changes in Cellular Structure May Lead to Early Detection of Cancerous Cells

Researchers have developed a new approach to characterizing and monitoring changes in cellular structure. The new type of single-cell-based assay, developed by researchers at Roswell Park Cancer Institute and the University at Buffalo, may provide a tool for detecting cancerous cells early and monitoring cell-to-cell variations in cancer progression or in response to pharmaceutical drugs.
News

Roswell Park Researchers Receive Grants to Study New Anticancer Agent in Lung, Colorectal, Gastrointestinal Cancers

Researchers at Roswell Park Comprehensive Cancer Center have garnered three of four grants awarded by the National Comprehensive Cancer Network Oncology Research Program to evaluate and define the clinical effectiveness of the investigational compound nintedanib, also known as BIBF 1120. These grants were made possible through general research funding provided to NCCN from Boehringer Ingelheim Pharmaceuticals Inc.